我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
8
6 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2010
已完成
2
25.0%
尚未招募
6
75.0%
暂无批准数据
- Stereotaxis received regulatory approval in China for its Magbot magnetic navigation ablation catheter, designed for minimally invasive cardiac procedures. - The approval follows recent clearance for Stereotaxis' Genesis robotic magnetic navigation system, expanding its footprint in the Chinese market. - Magbot, developed with MicroPort EP, integrates with robotic systems for precise navigation and real-time 3D cardiac modeling. - NMPA approved Magbot for treating drug-resistant persistent AFib, atrioventricular nodal reentrant tachycardia, and atrioventricular reentrant tachycardia.
